Protein microarray is an emerging technology that provides a versatile platform for characterization of thousands of proteins. There are two major classes of protein microarrays namely analytical and functional protein microarrays. Additionally, tissue or cell samples can also be isolated and spotted on a slide to form a reverse-phase protein microarray. While the fabrication technology is maturing, applications of protein microarrays, especially functional protein microarrays have been flourished during the past decade. The research for novel proteins includes detection of various binding properties of proteins, profiling antibody specificity, and biomarkers identification in autoimmune diseases. Protein microarray is a powerful technology platform and is anticipated to be one of the leading technologies in the proteomic and diagnostic fields in the coming years.
Get a sample report at https://www.marketresearchfuture.com/sample_request/5310 .
Global protein microarray consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas are expected to lead the global market due to the high incidence of cancer and infectious diseases. According to the American Cancer Society, more than 1,665,540 new cases of cancers were diagnosed in the U.S. in 2014. While Europe is expected to hold the second largest market share in the global market.
Asia Pacific region is expected to witness significant growth owing to increasing case of cancer and growing awareness regarding the diagnosis of infectious diseases. In addition, increasing healthcare expenditure related to cancer and associated disease is expected to boost the market growth in near future. This has led to an increase in the government spending on healthcare services in India and China.
The global protein microarray is segmented on the basis of type, application, product, technology, and end-users.
On the basis of the type, the global protein microarray market is segmented into protein chips, lab-on-chips (microfluidics), integrated systems, arrayers, and microarray systems.
On the basis of the application, the global protein microarray market is segmented into diagnostics, proteomics, protein functional analysis, and antibody characterization
On the basis of the product, the global protein microarray market is segmented into protein microarray instruments, protein microarray reagents, and protein microarray services.
On the basis of the technology, the global protein microarray market is segmented into analytical microarrays, functional protein microarrays, and reverse phase protein microarray
On the basis of the end user, the global protein microarray market has been segmented into hospitals, clinics, diagnostic centers, academic institutes, research centers, and others.
Browse Complete Report at https://www.marketresearchfuture.com/reports/protein-microarray-market-5310 .
Some of key the players in the global protein microarray market are Thermo Fisher Scientific (U.S), Agilent Technologies (U.S.), F. Hoffmann-La Roche AG (Genentech) (Switzerland), Illumina Inc. (U.S.), Abbott Laboratories (U.S.), PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), SEQUENOM, Inc. (U.S.), Sigma Aldrich Corporation (U.S.), Affymetrix, Inc. (U.S.), EMD Millipore (U.S.), Medtronic Inc. (U.S.), Angioscore Ltd. (U.S.) and others.
Proteomics instruments, reagents, and testing are needed to discover new biomarkers and even new drugs. The market has crossed 5 billion dollars in 2013. Though a number of tests are available in the market for protein analysis, the microarray is the efficient and fastest revenue generating technique. Improvement in generating high-quality proteins and antibodies will play a key role in the quantitative analysis and promote the extension of this technology to other organisms.
Despite the considerable investments made by several companies, the low availability of proteins in the market. Proteins are highly sensitive to changes in their microenvironment. This presents a challenge in maintaining protein arrays in a stable condition over extended periods of time. Declining production of consistent and reliable proteins due to low yield may hamper the market growth over the forecast period 2017-2023.
More Inquire at https://www.marketresearchfuture.com/enquiry/5310 .
The Americas are projected to hold the largest share of the global protein microarray market. Moreover, U.S. dominated the overall market in terms of revenue in 2017. National expenditures on cancer care in the United States was USD ~125 billion in 2010 and could reach USD 156 billion by 2020. According to the American Cancer Society in 2017, approximately 16, 88,780 new cases of cancer were believed to be diagnosed. The high incidence rate of cancer, increase in awareness about this condition, rise in focus on healthcare, and well-established healthcare infrastructure is some of the factors driving the North American market growth.
Europe holds the second largest share of the global protein microarray treatment market attributed to changing lifestyle and increasing R&D activities for the development of new drugs. The European protein microarray market is expected to show a rapid growth during the forecast period.
The Asia Pacific is estimated to be the fastest growing region during the forecast period due to increasing government funding, rising awareness among people regarding personalized medicine, growing prevalence and incidence rate of cancer. Additionally, increasing adoption of protein chip in emerging economies such as China, India, and others is likely to create new opportunities for the protein microarray market. The Middle East & African market is projected to expand during the forecast period owing to the rising investments by the market players and increasing adoption of protein microarrays for diagnostic purpose.
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –